Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 30 | 2023 | 2895 | 1.690 |
Why?
|
Alzheimer Disease | 34 | 2024 | 8760 | 0.710 |
Why?
|
Lewy Body Disease | 7 | 2024 | 253 | 0.700 |
Why?
|
Amyloid beta-Peptides | 16 | 2024 | 3913 | 0.640 |
Why?
|
Perimenopause | 2 | 2021 | 142 | 0.630 |
Why?
|
Vasomotor System | 1 | 2019 | 208 | 0.610 |
Why?
|
Activities of Daily Living | 13 | 2023 | 2434 | 0.560 |
Why?
|
alpha-Synuclein | 6 | 2017 | 774 | 0.560 |
Why?
|
Cultural Diversity | 2 | 2020 | 373 | 0.480 |
Why?
|
Nasal Obstruction | 3 | 2021 | 163 | 0.450 |
Why?
|
Disease Progression | 22 | 2023 | 13674 | 0.440 |
Why?
|
Rhinoplasty | 3 | 2021 | 241 | 0.400 |
Why?
|
Cholecalciferol | 2 | 2014 | 557 | 0.400 |
Why?
|
Calciphylaxis | 2 | 2024 | 129 | 0.390 |
Why?
|
Longitudinal Studies | 29 | 2024 | 14794 | 0.370 |
Why?
|
Apathy | 4 | 2017 | 107 | 0.360 |
Why?
|
Cognition Disorders | 13 | 2021 | 3985 | 0.360 |
Why?
|
Neuropsychological Tests | 25 | 2024 | 7148 | 0.350 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 2 | 2024 | 209 | 0.340 |
Why?
|
Glucosylceramidase | 3 | 2021 | 125 | 0.340 |
Why?
|
tau Proteins | 9 | 2024 | 2146 | 0.330 |
Why?
|
Memory | 7 | 2023 | 2209 | 0.330 |
Why?
|
Nasal Septum | 2 | 2020 | 131 | 0.300 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 1388 | 0.290 |
Why?
|
Migraine Disorders | 1 | 2019 | 1713 | 0.270 |
Why?
|
Aging | 13 | 2020 | 8745 | 0.260 |
Why?
|
Aged | 77 | 2024 | 171786 | 0.260 |
Why?
|
Caregivers | 4 | 2023 | 2308 | 0.260 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2021 | 417 | 0.260 |
Why?
|
Humans | 142 | 2025 | 768970 | 0.250 |
Why?
|
Positron-Emission Tomography | 13 | 2024 | 6673 | 0.250 |
Why?
|
Female | 104 | 2025 | 397515 | 0.250 |
Why?
|
Anxiety | 7 | 2025 | 4672 | 0.240 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2018 | 6030 | 0.240 |
Why?
|
Statistics as Topic | 1 | 2011 | 2360 | 0.240 |
Why?
|
Cognition | 11 | 2023 | 7081 | 0.230 |
Why?
|
Hippocampus | 5 | 2024 | 3782 | 0.230 |
Why?
|
Male | 98 | 2024 | 365203 | 0.230 |
Why?
|
Research Design | 3 | 2023 | 6214 | 0.220 |
Why?
|
Gangliosidoses, GM2 | 1 | 2023 | 20 | 0.220 |
Why?
|
Infarction, Middle Cerebral Artery | 2 | 2024 | 487 | 0.220 |
Why?
|
Lasers | 2 | 2018 | 952 | 0.220 |
Why?
|
Brain | 13 | 2020 | 27453 | 0.220 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2021 | 1039 | 0.210 |
Why?
|
Social Participation | 3 | 2021 | 187 | 0.210 |
Why?
|
Aged, 80 and over | 39 | 2024 | 59739 | 0.210 |
Why?
|
Dendritic Cells | 3 | 2018 | 2748 | 0.210 |
Why?
|
Haptoglobins | 1 | 2024 | 165 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10400 | 0.200 |
Why?
|
Hyperbaric Oxygenation | 1 | 2023 | 166 | 0.200 |
Why?
|
Galactosyltransferases | 1 | 2024 | 284 | 0.200 |
Why?
|
Depression | 9 | 2025 | 8231 | 0.200 |
Why?
|
Rats, Inbred Lew | 1 | 2024 | 1163 | 0.200 |
Why?
|
Iodine | 1 | 2024 | 286 | 0.190 |
Why?
|
Cross-Sectional Studies | 25 | 2024 | 26395 | 0.190 |
Why?
|
Cyclonic Storms | 1 | 2023 | 121 | 0.180 |
Why?
|
Carbolines | 3 | 2021 | 295 | 0.180 |
Why?
|
Cerebral Cortex | 6 | 2021 | 5831 | 0.180 |
Why?
|
Dacryocystitis | 1 | 2021 | 68 | 0.180 |
Why?
|
Dementia | 5 | 2017 | 2741 | 0.180 |
Why?
|
Middle Aged | 56 | 2024 | 223737 | 0.180 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 145 | 0.180 |
Why?
|
Sciatic Nerve | 1 | 2024 | 628 | 0.170 |
Why?
|
Stroke | 5 | 2024 | 9756 | 0.170 |
Why?
|
Anesthetics, Dissociative | 1 | 2020 | 81 | 0.170 |
Why?
|
Skin | 3 | 2018 | 4506 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 468 | 0.170 |
Why?
|
Vaccines | 2 | 2018 | 843 | 0.170 |
Why?
|
Brain Mapping | 3 | 2014 | 6739 | 0.170 |
Why?
|
Putamen | 1 | 2021 | 292 | 0.170 |
Why?
|
Erythrocytes, Abnormal | 1 | 2020 | 121 | 0.170 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 118 | 0.170 |
Why?
|
Entorhinal Cortex | 2 | 2023 | 288 | 0.170 |
Why?
|
Splenomegaly | 1 | 2020 | 192 | 0.170 |
Why?
|
Protein Precursors | 1 | 2024 | 1135 | 0.170 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2020 | 110 | 0.160 |
Why?
|
Infrared Rays | 2 | 2018 | 249 | 0.160 |
Why?
|
Apolipoprotein E4 | 5 | 2021 | 712 | 0.160 |
Why?
|
Dermatologic Agents | 1 | 2023 | 313 | 0.160 |
Why?
|
Peptide Fragments | 4 | 2014 | 5151 | 0.160 |
Why?
|
Adjuvants, Immunologic | 3 | 2018 | 999 | 0.160 |
Why?
|
Delirium | 2 | 2021 | 1696 | 0.160 |
Why?
|
Cardiopulmonary Bypass | 2 | 2021 | 1097 | 0.160 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 337 | 0.150 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 210 | 0.150 |
Why?
|
Nerve Regeneration | 1 | 2024 | 799 | 0.150 |
Why?
|
Aniline Compounds | 8 | 2017 | 1095 | 0.150 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1094 | 0.150 |
Why?
|
Radius Fractures | 1 | 2024 | 515 | 0.150 |
Why?
|
Acne Vulgaris | 1 | 2023 | 352 | 0.150 |
Why?
|
Clinical Chemistry Tests | 1 | 2018 | 59 | 0.150 |
Why?
|
Brain Ischemia | 2 | 2021 | 3008 | 0.150 |
Why?
|
Kidney Calculi | 1 | 2022 | 469 | 0.150 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2021 | 605 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2021 | 458 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36854 | 0.140 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 877 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 359 | 0.140 |
Why?
|
Autistic Disorder | 6 | 1992 | 1240 | 0.140 |
Why?
|
Electroencephalography | 6 | 2023 | 6317 | 0.140 |
Why?
|
Alopecia Areata | 1 | 2019 | 130 | 0.140 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 586 | 0.130 |
Why?
|
Epilepsy | 2 | 2023 | 3326 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 216 | 0.130 |
Why?
|
Thiazoles | 8 | 2017 | 1542 | 0.130 |
Why?
|
Hot Flashes | 1 | 2019 | 330 | 0.130 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3859 | 0.130 |
Why?
|
Patient Preference | 2 | 2023 | 947 | 0.130 |
Why?
|
Prospective Studies | 15 | 2024 | 54962 | 0.130 |
Why?
|
Nerve Degeneration | 3 | 2011 | 750 | 0.130 |
Why?
|
Gaucher Disease | 1 | 2016 | 110 | 0.130 |
Why?
|
Dyskinesia, Drug-Induced | 3 | 1991 | 165 | 0.130 |
Why?
|
Child Health Services | 1 | 2021 | 645 | 0.130 |
Why?
|
Tropanes | 1 | 2015 | 48 | 0.130 |
Why?
|
Celiac Disease | 1 | 2024 | 820 | 0.130 |
Why?
|
Transplantation, Heterologous | 1 | 2024 | 2395 | 0.130 |
Why?
|
Psychomotor Performance | 3 | 2019 | 1894 | 0.120 |
Why?
|
Telephone | 1 | 2019 | 630 | 0.120 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1263 | 0.120 |
Why?
|
Motor Activity | 2 | 2015 | 2713 | 0.120 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3683 | 0.120 |
Why?
|
Respiratory Mechanics | 1 | 2019 | 722 | 0.120 |
Why?
|
Hydrocephalus | 1 | 2021 | 770 | 0.120 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 917 | 0.120 |
Why?
|
Lymphedema | 1 | 2021 | 526 | 0.120 |
Why?
|
Ketamine | 1 | 2020 | 527 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2015 | 1998 | 0.120 |
Why?
|
Low Back Pain | 1 | 2023 | 990 | 0.110 |
Why?
|
Parietal Lobe | 2 | 2017 | 866 | 0.110 |
Why?
|
Glucose Tolerance Test | 3 | 2022 | 1183 | 0.110 |
Why?
|
Affect | 1 | 2021 | 1500 | 0.110 |
Why?
|
Awareness | 1 | 2018 | 653 | 0.110 |
Why?
|
Quantitative Trait Loci | 2 | 2020 | 2133 | 0.110 |
Why?
|
Schools, Medical | 1 | 2020 | 883 | 0.110 |
Why?
|
Analgesics | 1 | 2020 | 1071 | 0.110 |
Why?
|
Hallucinations | 2 | 2013 | 375 | 0.110 |
Why?
|
Environment Design | 1 | 2015 | 174 | 0.110 |
Why?
|
Amyloid | 2 | 2023 | 854 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2020 | 1309 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1183 | 0.110 |
Why?
|
Vision Disorders | 1 | 2020 | 1093 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11932 | 0.110 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15951 | 0.100 |
Why?
|
Disability Evaluation | 2 | 2018 | 1839 | 0.100 |
Why?
|
Neocortex | 1 | 2016 | 417 | 0.100 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39394 | 0.100 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1423 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1398 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2015 | 755 | 0.100 |
Why?
|
Mental Status Schedule | 2 | 2014 | 315 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2020 | 1226 | 0.100 |
Why?
|
Genetic Loci | 1 | 2021 | 2630 | 0.100 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1065 | 0.100 |
Why?
|
Synapses | 1 | 2021 | 1764 | 0.090 |
Why?
|
Laser Therapy | 1 | 2018 | 1110 | 0.090 |
Why?
|
Adult | 25 | 2025 | 223851 | 0.090 |
Why?
|
Neural Pathways | 2 | 2021 | 3120 | 0.090 |
Why?
|
Mast Cells | 1 | 2018 | 1406 | 0.090 |
Why?
|
Seizures | 2 | 2023 | 3000 | 0.090 |
Why?
|
Temporal Lobe | 3 | 2017 | 1728 | 0.090 |
Why?
|
Atrophy | 2 | 2023 | 1647 | 0.090 |
Why?
|
Autoantibodies | 1 | 2019 | 2120 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2059 | 0.090 |
Why?
|
Amyloidogenic Proteins | 2 | 2023 | 154 | 0.090 |
Why?
|
Insulin Resistance | 2 | 2022 | 3982 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 940 | 0.090 |
Why?
|
Contrast Media | 1 | 2024 | 5334 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2017 | 2734 | 0.090 |
Why?
|
Homocysteine | 2 | 2021 | 637 | 0.090 |
Why?
|
Retrospective Studies | 14 | 2024 | 81903 | 0.090 |
Why?
|
Pain Measurement | 1 | 2020 | 3586 | 0.090 |
Why?
|
Blood Glucose | 2 | 2022 | 6435 | 0.090 |
Why?
|
Bone Marrow | 1 | 2020 | 2936 | 0.080 |
Why?
|
Haloperidol | 2 | 1991 | 394 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2634 | 0.080 |
Why?
|
Students, Medical | 1 | 2023 | 1964 | 0.080 |
Why?
|
Influenza Vaccines | 1 | 2017 | 781 | 0.080 |
Why?
|
Health Promotion | 2 | 2021 | 2210 | 0.080 |
Why?
|
Pregnancy Complications | 2 | 2025 | 2974 | 0.080 |
Why?
|
Immunoassay | 1 | 2013 | 746 | 0.080 |
Why?
|
Multiple System Atrophy | 1 | 2011 | 132 | 0.080 |
Why?
|
Personality Assessment | 1 | 1991 | 646 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2013 | 1116 | 0.080 |
Why?
|
Apolipoproteins E | 4 | 2003 | 1461 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2649 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2017 | 2056 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3232 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1210 | 0.080 |
Why?
|
Insulin | 2 | 2022 | 6610 | 0.080 |
Why?
|
Vaccination | 2 | 2018 | 3438 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7058 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3278 | 0.080 |
Why?
|
Injections, Intradermal | 2 | 2018 | 117 | 0.070 |
Why?
|
Liver | 1 | 2024 | 7578 | 0.070 |
Why?
|
Patient Compliance | 1 | 2018 | 2701 | 0.070 |
Why?
|
Simvastatin | 1 | 2010 | 346 | 0.070 |
Why?
|
Cohort Studies | 9 | 2024 | 41808 | 0.070 |
Why?
|
Dopamine Agents | 1 | 2008 | 188 | 0.070 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2725 | 0.070 |
Why?
|
Memantine | 1 | 2008 | 111 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4820 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12801 | 0.070 |
Why?
|
Age of Onset | 4 | 2015 | 3346 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2164 | 0.070 |
Why?
|
Pilot Projects | 5 | 2025 | 8748 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4628 | 0.070 |
Why?
|
Alleles | 3 | 2016 | 6901 | 0.070 |
Why?
|
Sex Factors | 5 | 2020 | 10633 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2015 | 12806 | 0.070 |
Why?
|
Body Mass Index | 3 | 2021 | 13055 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2010 | 797 | 0.070 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 241 | 0.070 |
Why?
|
Child | 14 | 2024 | 80960 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1163 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2268 | 0.070 |
Why?
|
Histones | 2 | 2017 | 2603 | 0.060 |
Why?
|
Plaque, Amyloid | 1 | 2010 | 769 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1194 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2007 | 294 | 0.060 |
Why?
|
Morbidity | 2 | 2021 | 1757 | 0.060 |
Why?
|
Lipids | 1 | 2016 | 3345 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12562 | 0.060 |
Why?
|
Huntington Disease | 1 | 2011 | 1147 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3313 | 0.060 |
Why?
|
Age Factors | 6 | 2019 | 18435 | 0.060 |
Why?
|
Pregnancy | 5 | 2025 | 30265 | 0.050 |
Why?
|
Neurologic Examination | 2 | 2020 | 916 | 0.050 |
Why?
|
Life Style | 1 | 2015 | 3931 | 0.050 |
Why?
|
Thiosulfates | 1 | 2023 | 52 | 0.050 |
Why?
|
Speech Discrimination Tests | 1 | 2003 | 35 | 0.050 |
Why?
|
Memory Disorders | 5 | 2011 | 1202 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20776 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6611 | 0.050 |
Why?
|
Mental Recall | 2 | 2023 | 1226 | 0.050 |
Why?
|
Mice, Inbred C57BL | 7 | 2024 | 22379 | 0.050 |
Why?
|
Internship and Residency | 1 | 2023 | 5956 | 0.050 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20245 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5131 | 0.050 |
Why?
|
Prognosis | 6 | 2022 | 30046 | 0.050 |
Why?
|
Mice | 11 | 2024 | 82072 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18354 | 0.050 |
Why?
|
Amnesia | 1 | 2004 | 258 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6982 | 0.050 |
Why?
|
Animals | 14 | 2024 | 169335 | 0.050 |
Why?
|
Executive Function | 1 | 2011 | 1405 | 0.050 |
Why?
|
Video Games | 1 | 2025 | 202 | 0.050 |
Why?
|
Friends | 1 | 2023 | 148 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13510 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3591 | 0.050 |
Why?
|
Shoulder | 1 | 2024 | 300 | 0.050 |
Why?
|
Problem Solving | 1 | 2004 | 443 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8384 | 0.050 |
Why?
|
Isotretinoin | 1 | 2023 | 134 | 0.050 |
Why?
|
Minocycline | 1 | 2023 | 170 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5176 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 150 | 0.050 |
Why?
|
Florida | 1 | 2023 | 430 | 0.050 |
Why?
|
Verbal Learning | 3 | 2014 | 465 | 0.050 |
Why?
|
Weaning | 1 | 2021 | 102 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 143 | 0.050 |
Why?
|
Time Factors | 7 | 2023 | 40261 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 172 | 0.050 |
Why?
|
Discrimination Learning | 1 | 2003 | 278 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1369 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2913 | 0.050 |
Why?
|
Analysis of Variance | 2 | 1997 | 6236 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 808 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15471 | 0.050 |
Why?
|
Personal Autonomy | 1 | 2023 | 315 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2023 | 312 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7603 | 0.050 |
Why?
|
Bone Plates | 1 | 2024 | 468 | 0.040 |
Why?
|
Survival Analysis | 3 | 2021 | 10115 | 0.040 |
Why?
|
Semantics | 1 | 2004 | 618 | 0.040 |
Why?
|
Cyclothymic Disorder | 1 | 2020 | 42 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2021 | 187 | 0.040 |
Why?
|
Infarction | 1 | 2021 | 247 | 0.040 |
Why?
|
Receptors, Glutamate | 1 | 2001 | 229 | 0.040 |
Why?
|
Spin Labels | 1 | 2021 | 339 | 0.040 |
Why?
|
Depressive Disorder, Major | 2 | 2025 | 4818 | 0.040 |
Why?
|
Artifacts | 1 | 2008 | 1942 | 0.040 |
Why?
|
Regression Analysis | 3 | 2009 | 6346 | 0.040 |
Why?
|
Technology | 1 | 2022 | 296 | 0.040 |
Why?
|
Mutation | 3 | 2021 | 30266 | 0.040 |
Why?
|
Case-Control Studies | 6 | 2020 | 22296 | 0.040 |
Why?
|
Cellulitis | 1 | 2021 | 206 | 0.040 |
Why?
|
Pick Disease of the Brain | 1 | 2000 | 42 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2011 | 3411 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2023 | 12467 | 0.040 |
Why?
|
Decision Making | 2 | 2023 | 3953 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2001 | 308 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5891 | 0.040 |
Why?
|
Adolescent | 8 | 2019 | 89244 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2025 | 886 | 0.040 |
Why?
|
Levodopa | 2 | 2012 | 221 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6876 | 0.040 |
Why?
|
Hand | 1 | 2024 | 913 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11879 | 0.040 |
Why?
|
Area Under Curve | 1 | 2022 | 1645 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4356 | 0.040 |
Why?
|
Exercise | 1 | 2015 | 5954 | 0.040 |
Why?
|
Career Mobility | 1 | 2020 | 262 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Agnosia | 1 | 2018 | 66 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 366 | 0.040 |
Why?
|
Abscess | 1 | 2021 | 606 | 0.040 |
Why?
|
Poverty | 2 | 2021 | 2720 | 0.040 |
Why?
|
Cartilage | 1 | 2021 | 811 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 872 | 0.040 |
Why?
|
Choice Behavior | 1 | 2023 | 848 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2024 | 1599 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 101 | 0.030 |
Why?
|
Fracture Fixation, Internal | 1 | 2024 | 982 | 0.030 |
Why?
|
Pancreas | 1 | 2024 | 1700 | 0.030 |
Why?
|
Introns | 1 | 1999 | 969 | 0.030 |
Why?
|
Perfusion | 1 | 2021 | 1402 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 211 | 0.030 |
Why?
|
Haplotypes | 1 | 2023 | 2725 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2024 | 65480 | 0.030 |
Why?
|
Child Behavior Disorders | 2 | 1992 | 813 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2003 | 1008 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2018 | 579 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2017 | 216 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2019 | 402 | 0.030 |
Why?
|
Norway | 1 | 2017 | 501 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19023 | 0.030 |
Why?
|
Axons | 1 | 2024 | 1678 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5216 | 0.030 |
Why?
|
Association Learning | 1 | 1997 | 221 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 899 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3629 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 493 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8894 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1141 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 347 | 0.030 |
Why?
|
Drainage | 1 | 2021 | 1184 | 0.030 |
Why?
|
Psychiatry | 1 | 1988 | 1716 | 0.030 |
Why?
|
Spatial Behavior | 1 | 1995 | 88 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 198 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2515 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4076 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 584 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1625 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1056 | 0.030 |
Why?
|
Risk Factors | 7 | 2021 | 74976 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1049 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 9080 | 0.030 |
Why?
|
Comorbidity | 2 | 2025 | 10592 | 0.030 |
Why?
|
Neurons | 3 | 2010 | 9519 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1220 | 0.030 |
Why?
|
Space Perception | 1 | 1997 | 466 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3629 | 0.030 |
Why?
|
India | 1 | 2020 | 2334 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1694 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7478 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 593 | 0.030 |
Why?
|
Cytokines | 2 | 2019 | 7453 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5997 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21188 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
Risk | 2 | 2017 | 9621 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6547 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 13021 | 0.030 |
Why?
|
Mice, Hairless | 1 | 1993 | 39 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2533 | 0.030 |
Why?
|
Genotype | 4 | 2016 | 13048 | 0.030 |
Why?
|
Algorithms | 2 | 2017 | 14201 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 2660 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1216 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1616 | 0.030 |
Why?
|
Family Health | 1 | 2018 | 1255 | 0.030 |
Why?
|
Physical Examination | 1 | 2019 | 1262 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2015 | 283 | 0.030 |
Why?
|
Hair Diseases | 1 | 1993 | 72 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2023 | 2734 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14752 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 60131 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 4040 | 0.030 |
Why?
|
Pimozide | 1 | 1992 | 21 | 0.030 |
Why?
|
Patient Admission | 1 | 2019 | 1370 | 0.020 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 227 | 0.020 |
Why?
|
Apolipoprotein E3 | 1 | 2012 | 105 | 0.020 |
Why?
|
Rats | 2 | 2024 | 23786 | 0.020 |
Why?
|
Warfarin | 1 | 2020 | 1493 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1243 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2012 | 567 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21547 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3066 | 0.020 |
Why?
|
Leptin | 1 | 2019 | 1597 | 0.020 |
Why?
|
Actigraphy | 1 | 2015 | 527 | 0.020 |
Why?
|
Carbamazepine | 1 | 1992 | 224 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2011 | 438 | 0.020 |
Why?
|
Child, Preschool | 8 | 2024 | 42683 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12174 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 958 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2748 | 0.020 |
Why?
|
Hydroxycholesterols | 1 | 2010 | 23 | 0.020 |
Why?
|
Visual Acuity | 1 | 2020 | 2714 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2149 | 0.020 |
Why?
|
Cocaine | 1 | 2015 | 947 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3283 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2216 | 0.020 |
Why?
|
Prevalence | 3 | 2013 | 15879 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4940 | 0.020 |
Why?
|
Delusions | 1 | 2012 | 301 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5801 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2721 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2831 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17591 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3491 | 0.020 |
Why?
|
Stereotyped Behavior | 1 | 1990 | 134 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1794 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3682 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3952 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2010 | 248 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13318 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4251 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3813 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11116 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9565 | 0.020 |
Why?
|
Infant | 4 | 2024 | 36556 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1209 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 968 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 1903 | 0.020 |
Why?
|
Lithium | 1 | 1991 | 600 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6526 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3904 | 0.020 |
Why?
|
Naltrexone | 1 | 1990 | 319 | 0.020 |
Why?
|
Visual Perception | 1 | 1995 | 1407 | 0.020 |
Why?
|
Aggression | 1 | 1992 | 750 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 3037 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2001 | 1904 | 0.020 |
Why?
|
Imipramine | 1 | 1986 | 98 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2011 | 778 | 0.020 |
Why?
|